CTKB — Cytek Biosciences, Inc.

—
Nasdaq · Unknown · Unknown · CIK 1831915 ·
Last close
$5.70
Market Cap
$745.47M
52W High
$6.34
52W Low
$3.31
ADV30
1,344,721
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 53,229,000 31,206,000 -8,423,000 -6,097,000 446,145,000 66,806,000 124,791,000
Jun 2026 48,140,000 28,340,000 -11,400,000 -12,158,000 446,934,000 73,846,000 124,980,000
Mar 2026 44,135,000 21,254,000 -18,463,000 -18,866,000 449,113,000 65,665,000 121,469,000
Dec 2025 62,141,000 32,885,000 -5,594,000 -44,076,000 461,542,000 90,853,000 119,803,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,591,000
Investing CF
$-23,699,000
Financing CF
$1,379,000
CapEx
$-7,027,000
Dividends Paid
—
Buybacks
$34,000
EPS Diluted TTM
$-0.63
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-138,858,000
Inventory
$52,371,000
Receivables
$60,779,000
ST Investments
$189,093,000
EBIT TTM
$-39,877,000
Pretax Income TTM
$-39,955,000
Interest Exp TTM
$78,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$207,644,992
EBITDA
$-38,797,000
Free Cash Flow
$8,611,250
Enterprise Value
$531,258,528
Total Cash
$255,899,008
Total Debt
$24,687,000
Shares Out
130,783,967
Trailing EPS
$-0.63
Book Value
$2.46
ROE
-23.2%
ROA
-6.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 201,493,000 -40,384,000 -66,539,000 461,542,000 119,803,000 341,739,000 -4,686,000
Dec 2024 200,453,000 -20,523,000 -6,020,000 499,500,000 103,763,000 395,737,000 25,379,000
Dec 2023 193,015,000 -27,845,000 -12,148,000 494,457,000 101,393,000 393,064,000 5,281,000
Dec 2022 164,036,000 -1,804,000 2,576,000 519,476,000 93,930,000 425,295,000 -12,231,000

TTM Snapshot

Revenues TTM
$206,709,000
NetIncome TTM
$-80,578,000
OpCashFlow TTM
—
Assets (Latest)
$446,934,000
Forward EPS
$0.07

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $5.92 · call volume: 6 · put volume: 0
Expected Move to 2027-04-16: ±$4.11 (69.43%) — implied range $1.81 – $10.03 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MSSHY Mitsui-Soko Holdings Co Limited/ADR $745.80M $9.97 —
APEI AMERICAN PUBLIC EDUCATION INC $745.06M $40.93 —
EOI Eaton Vance Enhanced Equity Income Fund $744.59M $18.16 —
CPPKF Faraday Copper Corp. $741.70M $2.52 —
MEGI NYLIM CBRE Global Infrastructure Megatrends Term Fund $740.64M $14.23 —

News headlines (Yahoo Finance, 1h cache)

Cytek Biosciences to Participate in Upcoming Investor Conferences
2026-11-18 21:30 · Yahoo
Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year
2026-11-05 22:00 · Yahoo
Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript
2026-11-05 18:29 · Yahoo
Cytek Biosciences, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Cytek Biosciences Inc (CTKB) Q3 2026 Earnings Call Highlights: U.S. ...
2026-11-05 05:16 · Yahoo
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
2026-11-04 23:45 · Yahoo
Cytek Biosciences Q3 Earnings Call Highlights
2026-11-04 23:14 · Yahoo
Cytek Biosciences Reports Third Quarter 2026 Financial Results
2026-11-04 21:05 · Yahoo
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
2026-10-28 13:00 · Yahoo
Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability
2026-10-25 00:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.